Literature DB >> 15007308

Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.

Bo Kyung Sun1, Can Li, Sun Woo Lim, Ju Young Jung, Suk Hee Lee, In San Kim, Yong Soo Kim, Jin Kim, Byung Kee Bang, Chul Woo Yang.   

Abstract

Up-regulation of transforming growth factor-beta (TGF-beta) is known to play an important role in the tubulointerstitial injury of chronic cyclosporin A (CsA) nephropathy, but the expression of the TGF-beta-inducible gene-h3 (betaig-h3) is undetermined. In this study we examined betaig-h3 expression and its relationship to tubulointerstitial injury in a rat model of chronic CsA nephropathy. Sprague-Dawley rats kept on a low-salt diet (0.05% sodium) were treated daily for 4 weeks with subcutaneous injections of vehicle (olive oil, 1 mL/kg) or CsA (15 mg/kg). The expression of betaig-h3 messenger RNA (mRNA) and protein was evaluated with the use of in situ hybridization, immunohistochemical methods, and immunoblotting. We also compared renal function, histologic findings (tubulointerstitial fibrosis), and expression of TGF-beta1 among treatment groups. In vehicle-treated kidney, betaig-h3 mRNA and protein were constitutively expressed in the outer medulla and cortex, which was confined to the terminal portion of afferent arterioles, the S3 segment of the proximal tubules, and distal convoluted tubules. CsA treatment significantly up-regulated betaig-h3 expression in the interstitium, especially in expanded and fibrotic areas. Quantitative analysis revealed that CsA induced a significant (twofold) increase in betaig-h3 mRNA and protein, and this increase was correlated with up-regulation of TGF-beta1 expression (r =.943, P <.001) and the tubulointerstitial fibrosis score (r =.746, P =.05). Our observations indicate that an increase in betaig-h3 expression, along with TGF-beta1 up-regulation, is closely associated with tubulointerstitial fibrosis in a rat model of chronic CsA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007308     DOI: 10.1016/j.lab.2003.10.014

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

Review 1.  Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.

Authors:  Eu Jin Lim; Ruth Chin; Peter W Angus; Joseph Torresi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

2.  A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.

Authors:  Annamaria De Luca; Beatrice Nico; Antonella Liantonio; Maria Paola Didonna; Bodvael Fraysse; Sabata Pierno; Rosa Burdi; Domenica Mangieri; Jean-François Rolland; Claudia Camerino; Alberta Zallone; Paolo Confalonieri; Francesca Andreetta; Elisa Arnoldi; Isabelle Courdier-Fruh; Josef P Magyar; Antonio Frigeri; Michela Pisoni; Maria Svelto; Diana Conte Camerino
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 3.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

4.  Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.

Authors:  Eu Jin Lim; Ruth Chin; Ueli Nachbur; John Silke; Zhiyuan Jia; Peter W Angus; Joseph Torresi
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

Review 5.  Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy.

Authors:  Kang Luo; Sun Woo Lim; Yi Quan; Sheng Cui; Yoo Jin Shin; Eun Jeong Ko; Byung Ha Chung; Chul Woo Yang
Journal:  Oxid Med Cell Longev       Date:  2019-10-17       Impact factor: 6.543

6.  Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse.

Authors:  Long T Nguyen; Sonia Saad; Ying Shi; Rosy Wang; Angela S Y Chou; Anthony Gill; Yimin Yao; Wolfgang Jarolimek; Carol A Pollock
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 7.  Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.